To investigate the role of dopamine D4 receptor (D4R) in the development of normal refraction and form-deprivation myopia (FDM) by applying D4R agonist PD-168077 and D4R antagonist L-745870 in mice. Methods: This was an animal experimental study. Four-week-old C57BL/6 mice were raised either in a visually normal environment or subjected to FDM by covering one eye with vision obstructing goggles while the other eye served as the normal control. Both groups were divided into sub-groups including vehicle and drug groups (D4R agonist PD-168077: 1 mg/kg/day and 10 mg/kg/day; D4R antagonist L-745870: 1 mg/kg/day and 10 mg/kg/day). They were intraperitoneally injected daily for two weeks. ERG was measured in normal enviroment mice on postnatal day 35. Refraction, corneal curvature radius, and ocular axial components were measured in all animals prior to and after each experiment. Statistical analyses were performed by a paired t test, one-way ANOVA, and repeated measurement ANOVA. Results: Normal refractive development was not affected by D4R agonist PD-168077 treatment. On the other hand, the D4R antagonist L-745870 enhanced normal refractive development towards hyperopia at a dose of 10 mg/kg (P=0.047) with no significant changes in other biometric parameters. PD-168077 increased the ERG OPs amplitude under scotopic conditions at an intensity of -0.699 log cdsm-2 (P=0.04), while L-745870 had no significant effect on the a-wave, b-wave, or summed OPs amplitudes under scotopic and photopic conditions. The development of FDM was promoted by PD-168077 treatment (P=0.004), with increases in both vitreous chamber depth and axial length. In contrast, D4R antagonist L-745870, inhibited FDM (P<0.001), with a shortened vitreous chamber depth and axial length. No significant changes in anterior chamber depth, lens thickness or corneal curvature radius were observed. Conclusions: D4R is activated or inactivated had no significant effects on normal refractive development in mice. In contrast, in a form-deprived environment, D4R is activated enhance while D4R inactivated inhibit FDM development, suggesting D4R activation enhances while D4R inactivation inhibits the development of myopia in mice.
王琼思 周峰 谢利琴 黄芙蓉 瞿佳 周翔天. 多巴胺D4受体对正常屈光发育及形觉剥夺性近视小鼠的作用[J]. 中华眼视光学与视觉科学杂志, 2019, 21(4): 270-279.
Qiongsi Wang, Feng Zhou, Liqin Xie, Furong Huang, Jia Qu, Xiangtian Zhou. Contributions of Dopamine D4 Receptor Modulation to the Development of Normal Refraction and Form-Deprivation Myopia in Mice. Chinese Journal of Optometry Ophthalmology and Visual science, 2019, 21(4): 270-279. DOI: 10.3760/cma.j.issn.1674-845X.2019.04.006
Dolgin E. The myopia boom. Nature, 2015, 519(7543): 276-278. DOI: 10.1038/519276a.
[2]
Marcus MW, de Vries MM, Junoy MFG, et al. Myopia as a risk factor for open-angle glaucoma: A systematic review and metaanalysis.Ophthalmology, 2011, 118(10): 1989-1994.e2. DOI:10.1016/j.ophtha.2011.03.012.
[3]
Wu LJ, Wang YX, You QS, et al. Risk factors of myopic shift among primary school children in Beijing, China: A prospective study. Int J Med Sci, 2015, 12(8): 633-638. DOI: 10.7150/ijms.12133.
[4]
Pan CW, Ramamurthy D, Saw SM. Worldwide prevalence and risk factors for myopia. Ophthalmic Physiol Opt, 2012, 32(1):3-16. DOI: 10.1111/j.1475-1313.2011.00884.x.
[5]
Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology,2002, 109(4): 704-711.
[6]
Chou SC, Yang CH, Lee CH, et al. Characteristics of primary rhegmatogenous retinal detachment in Taiwan. Eye (Lond),2007, 21(8): 1056-1061. DOI: 10.1038/sj.eye.6702397.
[7]
Saw SM, Carkeet A, Chia KS, et al. Component dependent risk factors for ocular parameters in Singapore Chinese children.Ophthalmology, 2002, 109(11): 2065-2071.
Dowling JE, Ehinger B. Synaptic organization of the dopaminergic neurons in the rabbit retina. J Comp Neurol, 1978,180(2): 203-220. DOI: 10.1002/cne.901800202.
[10]
Dowling JE, Ehinger B. The interplexiform cell system. I.Synapses of the dopaminergic neurons of the goldfish retina.Proc R Soc Lond B Biol Sci, 1978, 201(1142): 7-26. DOI:
10
1098/rspb.1978.0030.
[11]
Frederick JM, Rayborn ME, Laties AM, et al. Dopaminergic neurons in the human retina. J Comp Neurol, 1982, 210(1): 65-79. DOI: 10.1002/cne.902100108.
[12]
Witkovsky P. Dopamine and retinal function. Doc Ophthalmol,2004, 108(1): 17-40.
Feldkaemper M, Schaeffel F. An updated view on the role of dopamine in myopia. Exp Eye Res, 2013, 114(2): 106-119. DOI:10.1016/j.exer.2013.02.007.
[15]
Nir I, Harrison JM, Haque R, et al. Dysfunctional light-evoked regulation of cAMP in photoreceptors and abnormal retinal adaptation in mice lacking dopamine D4 receptors. J Neurosci,2002, 22(6): 2063-2073.
[16]
Li H, Zhang Z, Blackburn MR, et al. Adenosine and dopamine receptors coregulate photoreceptor coupling via gap junction phosphorylation in mouse retina. J Neurosci, 2013, 33(7): 3135-3150. DOI: 10.1523/JNEUROSCI.2807-12.2013.
[17]
Cohen AI, Todd RD, Harmon S, et al. Photoreceptors of mouse retinas possess D4 receptors coupled to adenylate cyclase. Proc Natl Acad Sci USA, 1992, 89(24): 12093-12097.
[18]
Kay JN, De la Huerta I, Kim IJ, et al. Retinal ganglion cells with distinct directional preferences differ in molecular identity, structure, and central projections. J Neurosci, 2011, 31(21):7753-7762. DOI: 10.1523/JNEUROSCI.0907-11.2011.
[19]
Jackson CR, Ruan GX, Aseem F, et al. Retinal dopamine mediates multiple dimensions of light-adapted vision. J Neurosci, 2012,32(27): 9359-9368. DOI: 10.1523/JNEUROSCI.0711-12.2012.
[20]
Aung MH, Park HN, Han MK, et al. Dopamine deficiency contributes to early visual dysfunction in a rodent model of type1 diabetes. J Neurosci, 2014, 34(3): 726-736. DOI: 10.1523/
JNEUROSCI.3483-13.2014.
[21]
Ward AH, Siegwart JT, Frost MR, et al. Intravitreally-administered dopamine D2-Like (and D4), but not D1-like, receptor agonists reduce form-deprivation myopia in tree shrews. Vis Neurosci,2017, 34 E003. DOI: 10.1017/S0952523816000195.
[22]
Huang F, Yan T, Shi F, et al. Activation of dopamine D2 receptor is critical for the development of form-deprivation myopia in the C57BL/6 mouse. Invest Ophthalmol Vis Sci, 2014, 55(9): 5537-5544. DOI: 10.1167/iovs.13-13211.
Yan T, Xiong W, Huang F, et al. Daily injection but not continuous infusion of apomorphine inhibits form-deprivation myopia in mice. Invest Ophthalmol Vis Sci, 2015, 56(4): 2475-2485. DOI:10.1167/iovs.13-12361.
[25]
Ko F, Seeman P, Sun WS, et al. Dopamine D2 receptors internalize in their low-affinity state. Neuroreport, 2002, 13(8):1017-1020.
[26]
Nowak JZ, Sek B, Schorderet M. Dark-induced supersensitivity of dopamine D-1 and D-2 receptors in rat retina. Neuroreport,1991, 2(8): 429-432.
[27]
Dong F, Zhi Z, Pan M, et al. Inhibition of experimental myopia by a dopamine agonist: different effectiveness between form deprivation and hyperopic defocus in guinea pigs. Mol Vis,2011, 17(12): 2824-2834.
[28]
Papastergiou GI, Schmid GF, Laties AM, et al. Induction of axial eye elongation and myopic refractive shift in one-year-old chickens. Vision Res, 1998, 38(12): 1883-1888.
[29]
Chakraborty R, Park HN, Hanif AM, et al. ON pathway mutations increase susceptibility to form-deprivation myopia. Exp Eye Res,2015, 137: 79-83. DOI: 10.1016/j.exer.2015.06.009.
[30]
Hn P, Jabbar SB, Tan CC, et al. Visually-driven ocular growth in mice requires functional rod photoreceptors. Invest Ophthalmol Vis Sci, 2014, 55(10): 6272-6279. DOI: 10.1167/iovs.14-14648.
[31]
Wu XH, Li YY, Zhang PP, et al. Unaltered retinal dopamine levels in a C57BL/6 mouse model of form-deprivation myopia.Invest Ophthalmol Vis Sci, 2015, 56(2): 967-977. DOI: 10.1167/iovs.13-13362.
[32]
Zhou X, Pardue MT, Iuvone PM, et al. Dopamine signaling and myopia development: What are the key challenges. Prog Retin Eye Res, 2017, 61: 60-71. DOI: 10.1016/j.preteyeres.2017.06.003.
[33]
Pardue MT, Stone RA, Iuvone PM. Investigating mechanisms of myopia in mice. Exp Eye Res, 2013, 114 96-105. DOI: 10.1016/j.exer.2012.12.014.
[34]
Prusky GT, Alam NM, Douglas RM. Enhancement of vision by monocular deprivation in adult mice. J Neurosci, 2006, 26(45):11554-11561. DOI: 10.1523/JNEUROSCI.3396-06.2006.
[35]
Vernier P, Legros-J N, Botteri-C V. Dopamine receptor localization in the mammalian retina. Mol Neurobiol, 1999,19(3): 181-204.